A. Eerenberg

发表

C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2

C. Hack, L. Thijs, A. Ogilvie, 2005, Intensive Care Medicine.

A model for the interplay of inflammatory mediators in sepsis —a study in 48 patients

C. Hack, L. Thijs, R. S. V. STRACK VAN SCHIJNDEL, 2005, Intensive Care Medicine.

Interleukin-8 in sepsis: relation to shock and inflammatory mediators

C. Hack, L. Thijs, A. Eerenberg, 1992, Infection and immunity.

Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies.

A. Eerenberg, J. Nuijens, J. Abbink, 1988, Journal of immunology.

Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees

T. van der Poll, H. Büller, C. Hack, 1994, The Journal of experimental medicine.

Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor.

C. Hack, A. Eerenberg, J. Nuijens, 1995, Blood.

Activation of the contact system in insect-sting anaphylaxis: association with the development of angioedema and shock.

V. Zwan, A. Eerenberg, J. van der Zwan, 1993, Blood.

Complement Activation in Relation to Capillary Leakage in Children with Septic Shock and Purpura

W. Hop, J. Hazelzet, A. Eerenberg, 1998, Infection and Immunity.

A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a.

L. Thijs, A. Eerenberg, J. Nuijens, 1988, Journal of immunological methods.

Detection of Activation of the Contact System of Coagulation In Vitro and In Vivo: Quantitation of Activated Hageman Factor-C1-Inhibitor and Kallikrein-C1-Inhibitor Complexes by Specific Radioimmunoassays

C. Hack, A. Eerenberg, J. Nuijens, 1987, Thrombosis and Haemostasis.

Quantification of Functional and Inactivated α2-Macroglobulin in Sepsis

C. Hack, L. Thijs, R. S. V. STRACK VAN SCHIJNDEL, 1991, Thrombosis and Haemostasis.

Effect of postponed treatment with an anti‐tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin‐induced cytokine and neutrophil responses in chimpanzees

S. Deventer, C. Hack, B. Haagmans, 1995, Clinical and experimental immunology.

Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease.

T. Kuijpers, A. Eerenberg, E. Endert, 2001, The Journal of infectious diseases.

Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern

C. Hack, A. Eerenberg, A. Chang, 1993, Infection and immunity.

Interleukin 12 induces activation of fibrinolysis and coagulation in humans

C. Hack, M. Schuler, A. Sparreboom, 2001, British journal of haematology.

Quantification of functional and inactivated alpha 2-macroglobulin in sepsis.

C. Hack, L. Thijs, R. S. V. STRACK VAN SCHIJNDEL, 1991, Thrombosis and haemostasis.

Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli.

C. Hack, A. Creasy, A. Eerenberg, 1993, Circulatory shock.

Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model

F B Taylor, C. Hack, A. Eerenberg, 1993, Infection and immunity.

Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.

R. Colman, C. Hack, L. Thijs, 1992, The Journal of laboratory and clinical medicine.

Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.

E. Hack, A. Eerenberg, J. Nuijens, 1990, The Journal of clinical investigation.

A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.

A. Eerenberg, J. Nuijens, J. Burggraaf, 2005, The Journal of allergy and clinical immunology.

Generation of plasmin during acute attacks of hereditary angioedema.

A. Eerenberg, J. P. de Boer, M. Cicardi, 1993, The Journal of laboratory and clinical medicine.

Plasma Levels of C 1 Inhibitor Complexes and Cleaved C 1 Inhibitor in Patients with Hereditary Angioneurotic Edema

E. Hack, A. Eerenberg, J. Nuijens, 2013 .

Studies on the Contact System of Coagulation during Therapy with High Doses of Recombinant IL-2: Implications for Septic Shock

L. Thijs, R. S. V. STRACK VAN SCHIJNDEL, A. Eerenberg, 1991, Thrombosis and Haemostasis.

Elevated nucleosome levels in systemic inflammation and sepsis*

B. Lämmle, C. Hack, A. van Nieuwenhuijze, 2003, Critical care medicine.

OKT3 and IL-2 Treatment for Purging of the Latent HIV-1 Reservoir in Vivo Results in Selective Long-Lasting CD4+ T Cell Depletion

H. Schuitemaker, C. Fox, A. Eerenberg, 2001, Journal of Clinical Immunology.

C1 ESTERASE INHIBITOR (C1-INH) CAN REDUCE PLASMA CONCENTRATIONS OF THE COMPLEMENT ACTIVATION PRODUCT C5A. AUTHOR'S REPLY

C. Hack, L. Thijs, J. McCormack, 1994 .

Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant

C. Hack, M. Schuler, A. Sparreboom, 2004, Cancer Immunology, Immunotherapy.

Apoptosis In Sepsis And Multiple Organ Dysfunction Syndrome

B. Lämmle, C. Hack, A. Groeneveld, 2004 .

A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2.

J. Baars, C. Hack, L. Thijs, 1994, British Journal of Cancer.

Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees

A. Eerenberg, Marcel Levi, Jaap Jansen, 1994, The Journal of experimental medicine.

Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.

A. Eerenberg, N. Friedmann, N. Wedel, 1995, The Journal of infectious diseases.